14.08.2017 • NewsCB&IconstructionElaine Burridge

CB&I to Sell Technology Business

(c) CB&I
(c) CB&I

US engineering contractor CB&I is putting its technology business up for sale as it struggles with falling revenues. The Texas-headquartered group reported a second-quarter loss of $425 million and revenues down more than 40% year over year.

“Although our second-quarter results are disappointing, we are taking decisive actions to improve our operating performance and strengthen the company’s financial position,” said president and CEO, Patrick Mullen. “We have initiated a comprehensive cost reduction program and suspended our dividend. Additionally, we are pursuing a sale of our technology business, which we believe will unlock significant value for stakeholders.”

Mullen said proceeds from the sale will be used to wipe out most of CB&I’s debt and reinvest in its engineering & construction and fabrication services businesses. “We envision a bright future for CB&I as a highly focused company with tightly integrated EPC [engineering, procurement and construction] and fabrication capabilities serving the LNG, petrochemical, refining and gas power generation markets.”

The technology business includes about 3,000 patents and patent application trademarks and more than 100 licensed technologies. CB&I is aiming to close the deal by the end of 2017. Mullen said the business consistently generates very attractive margins with minimal capital requirements, but was undervalued as part of CB&I. “Our intent is to negotiate a long-term strategic alliance with the ultimate buyer, which we believe could benefit both CB&I and the buyer,” he said.

In June, CB&I sold its capital services business to an affiliate of private equity firm Veritas Capital for $700 million. The contractor also sold its Stone & Webster nuclear construction business, which it acquired in 2012 as part of its $3 billion acquisition of The Shaw Group, to Westinghouse Electric for $229 million at the end of 2015.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.